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Abstract: The type 1 Boston Keratoprosthesis preparation requires a 3-mm central punch 
and an 8.5 mm or larger punch in the carrier tissue. These punches are ideally concentric, 
but we have found difficulty in achieving concentric punches when the larger punch is 
performed first. We present a modification in the preparation procedure to help minimize 
centration error.
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To the editor
The type 1 Boston Keratoprosthesis (KPro) is a poly (methyl methacrylate) device that 
has gained acceptance in many types of end-stage corneal diseases as a viable surgical 
option.1–3 The KPro is assembled using a carrier donor tissue, and its optics afford 
excellent visual acuity and field of vision4 assuming that the alignment of the KPro is 
optimized. Centration of the KPro is determined during preparation of the donor carrier 
tissue and host trephination. The manufacturer’s recommended steps for KPro prepa-
ration involve punching the donor with an 8.5 mm or greater diameter followed by a 
3-mm central punch. We have found that centration of the KPro in the carrier tissue 
can be difficult using this procedure, and we present a modification for   minimizing 
centration error.
Technique description
The center of the donor carrier tissue is marked using a surgical marker, and a 3-mm 
central punch is performed using the centration mark (Figure 1A). The accuracy 
requirement of centration in this step is not stringent. The 3-mm-diameter punched 
tissue is removed, and the edge is inspected. An appropriate outer diameter punch size 
is selected, which should be at least 8.5 mm diameter if possible, and a   disposable 
  Barron corneal punch (Katena Eye Instruments, Denville, NJ) is   typically used. The 
donor carrier tissue is placed on the punch block and the 3-mm hole is centered between 
the vacuum holes of the punch block (Figure 1B), and the vacuum is engaged. The 
punch is then carefully performed, and the KPro is assembled and sutured to the host 
rim (Figure 1C).
Discussion
The type 1 Boston KPro is a viable therapeutic option for many end-stage corneal 
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reported visual results of the KPro have been good.2,3 The 
assembly of the KPro involves preparation of a   carrier 
tissue with two punches that are ideally concentric. The 
manufacturer recommends punching the outer circle 
first and then the central 3-mm punch. We have found 
  difficulty in creating concentric punches using this tech-
nique   (Figure 2), and we believe that punching the central 
3-mm hole first and then using this hole to center within 
the Barron corneal punch’s four vacuum ports affords much 
better control. If the manufacturer’s recommendations 
are followed and the outer punch is performed first, then 
the free-hand 3-mm dermatologic punch must be placed 
perfectly for a concentric result.
The optical performance of the KPro on an optical 
bench using a 3-mm pupil and precise alignment was 
evaluated and found to produce a sharp, crisp image 
with a tight point-spread function.4 The optical cylinder, 
under these optimized alignment conditions, produced 
Figure 1 Preparation of the carrier tissue with a 3-mm dermatologic punch first (A). The 3-mm hole is then centered between the vacuum ports of the punch block to 
create 2 concentric punches (B). The keratoprosthesis optic is perfectly centered in the carrier tissue, minimizing scatter and other optical phenomena and allowing for 
easier suturing and better tension distribution (C).
  scattered ghost images when the 3-mm pupil was widened 
to 10 mm. If the alignment of the KPro is suboptimal with 
the cylinder off-axis from the fovea, then the projected 
image will most likely be further degraded. We believe 
the centration of the KPro in the donor carrier and host 
cornea is integral for optimal alignment of the cylinder 
and minimization of scatter and other optical phenomena. 
Our technique of punching the 3-mm inner hole first and 
then centering the outer punch on this hole relieves much 
centration uncertainty in KPro preparation. In addition to 
the optical advantages of optimizing centration, suturing 
to the host rim is much easier with better distribution 
of tension when the KPro is centered. We have not found 
any limitations or problems from this simple modification 
of Kpro assembly.
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Figure 2 Examples of type 1 Boston Keratoprosthesis when prepared with the outer punch first and then the 3-mm central punch. Centration measurements show that the 
keratoprosthesis optic is poorly centered in the donor tissue.Clinical Ophthalmology
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